Skip to main content
. 2010 Nov 19;13(2):262–269. doi: 10.1093/europace/euq418

Table 1.

General characteristics of patients at study enrolment

Total recruitment 570 (100%)
Women 306 (54%)
Age ± SD 61 ± 17
Primary Indication
 Unexplained syncope 517 (91%)
 Unexplained pre-syncope 42 (7%)
 Other 11 (2%)
History
 Hypertension 277 (49%)
 Coronary artery disease 84 (15%)
 Valvular heart disease 30 (5%)
 Cardiomyopathy 18 (3%)
 Stroke/TIA 57 (10%)
Diagnostic work-up before ILR implant
 In an initial phase of diagnostic work-up of syncope 128 (22%)
 After full evaluation of mechanism of syncope 386 (68%)
Device Implanted
 Reveal DX 264 (46%)
 Reveal XT 52 (9%)
 Reveal Plus 254 (45%)
Age at first syncope 55 ± 20
Previous syncopes median (IQ range) 4 (2–6)
Syncopes in the last 2 years median (IQ range) 3 (2–4)
Syncopal episodes per year median (IQ range) 2 (1–3.5)
Median interval between first and last episode years (IQ range) 2 (0–4)
Any previous hospitalization because of syncope 399 (70%)
Any syncopal episodes without prodromes 339 (59%)
Any syncopal episodes with severe trauma 204 (36%)
Any syncopal episodes suggestive of vasovagal origin 86 (15%)
Any situational syncope 39 (7%)
Characteristics of last syncope
 After effort 28 (5%)
 During effort 144 (25%)
 At rest 294 (52%)
 Unknown 97 (17%)
 Missing 7 (1%)
Symptoms
 Muscle spasms (one sided) 8 (1%)
 Muscle spasms (two sided) 19 (3%)
 Grand mal 10 (2%)
 Other muscle spasms 14 (2%)
 Transpiration 73 (13%)
 Cyanosis 19 (3%)
 Angina pectoris 23 (4%)
 Palpitations 76 (13%)
 Dizziness 163 (29%)
 Dyspnoea 33 (6%)
 Fatigue 95 (17%)
 Other 80 (14%)
 None 266 (47%)